<table class="infobox infobox-protein"> is a protein that foxa2 plays essential roles in:. [@geneprotein] This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Structure
FOXA2 (Forkhead Box A2), also known as HNF3β, is a transcription factor belonging to the Fox family. The protein contains:
Forkhead domain: A conserved DNA-binding domain of approximately 110 amino acids that recognizes the consensus sequence (G/A)(T/C)(A/C)AA(C/T)A
Transactivation domain: Located at the N-terminus for transcriptional activation
C-terminal domain: Involved in protein-protein interactions
FOXA2 binds to DNA as a monomer and functions as both a transcriptional activator and pioneer factor, opening chromatin to allow other transcription factors access. [@auto_38851846]
Normal Function
FOXA2 plays essential roles in:
Dopaminergic Neuron Development: Critical for specification and maintenance of midbrain dopaminergic [neurons](/entities/neurons)
Metabolic Regulation: Controls genes involved in glucose metabolism, lipid metabolism, and insulin signaling [@auto_35154496]
Endoderm Development: Essential for foregut endoderm formation during embryogenesis
Liver Function: Regulates hepatic gene expression and liver development
Pancreatic Development: Important for pancreatic islet cell function and insulin expression
FOXA2 regulates tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC), key enzymes in dopamine biosynthesis.
Role in Neurodegeneration
FOXA2 is implicated in several neurodegenerative processes:
Parkinson's Disease
Essential for dopaminergic neuron survival in the substantia nigra pars compacta
FOXA2 expression declines with age and in PD brains
Protects dopaminergic neurons from oxidative stress and mitochondrial dysfunction
Regulates expression of mitochondrial complex I subunits
Gene therapy with FOXA2 shows promise in PD models
Huntington's Disease
FOXA2 dysfunction contributes to metabolic disturbances in HD
Altered FOXA2 signaling affects brain energy metabolism
May influence striatal neuron vulnerability
Energy Metabolism
FOXA2 deficiency leads to impaired glucose metabolism
Energy deficit contributes to neurodegeneration
Links metabolic dysfunction to neuronal death
Therapeutic Targeting
FOXA2 is being explored as a therapeutic target: [@auto_36332622]
Gene Therapy: AAV-FOXA2 delivery to protect dopaminergic neurons
Small Molecule Activators: Compounds that enhance FOXA2 expression/activity [@auto_40419484]
Combination Therapy: FOXA2 with other transcription factors (e.g., LMX1A, PITX3) for dopaminergic rescue [@auto_37875418]
Metabolic Modulation: Targeting FOXA2 pathways to improve neuronal energy metabolism
Key Publications
[Kittappa et al. (2007). The role of FOXA2 in the maintenance of mesencephalic dopaminergic neurons. Molecular and Cellular Neuroscience](https://doi.org/10.1016/j.mcn.2007.05.008)
[Sgado et al. (2012). FOXA2 promotes the survival of dopaminergic neurons. Neural Development](https://doi.org/10.1186/1749-8104-7-23)
[Lee et al. (2015). FOXA2 protects against mitochondrial complex I defects and enhances dopaminergic neuronal survival. Human Molecular Genetics](https://doi.org/10.1093/hmg/ddv250)